Nägga K, Gustavsson AM, Stomrud E, Lindqvist D, van Westen D, Blennow K,  Zetterberg H, Melander O, Hansson O. Increased midlife triglycerides predict  brain β-amyloid and tau pathology 20 years later.Neurology. 2018 Jan 2;90(1):e73-e81. Epub 2017 Dec 1. OBJECTIVE: To evaluate the effect of midlife lipid levels on Alzheimer brain pathology 20 years later in cognitively normal […]

Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H, Blennow K, Landau S, Jagust W, Hansson O. Nature communications. 2017 Oct 31;8(1):1214.   Abstract It is not known exactly where amyloid-β (Aβ) fibrils begin to accumulate in individuals with Alzheimer’s disease (AD). Recently, we showed that abnormal levels of Aβ42 in cerebrospinal fluid […]

Janelidze S, Pannee J, Mikulskis A, Chiao P, Zetterberg H, Blennow K, Hansson O.  JAMA Neurology (in press).

Hansson O1, Palmqvist S2, Ljung H3, Cronberg T3, van Westen D4, Smith R5.

Smith R1, Schöll M2, Widner H2, van Westen D2, Svenningsson P2, Hägerström D2, Ohlsson T2, Jögi J2, Nilsson C2, Hansson O1.

Schöll M, Ossenkoppele R, Strandberg O, Palmqvist S, Jögi J, Ohlsson T, Smith R, Hansson O Brain, awx171, https://doi.org/10.1093/brain/awx171

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer’s disease.